HLA-G-dependent suppressor cells: Diverse by nature, function, and significance

Human Immunology

Volumn 69, Issue 11, 2008, Pages 700-707

  Carosella, Edgardo D ^a   HoWangYin, Kiave Yune ^a   Favier, Benoît ^a   LeMaoult, Joel ^a  

^a DIF   (France)

Author keywords

HLA G; Immune regulation; Regulatory cells

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; HLA G ANTIGEN; HLA G1 ANTIGEN; HLA G2 ANTIGEN; HLA G3 ANTIGEN; HLA G4 ANTIGEN; HLA G5 ANTIGEN; HLA G6 ANTIGEN; HLA G7 ANTIGEN; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; DENDRITIC CELL; ENDOTHELIUM CELL; HELPER CELL; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; MESENCHYMAL STEM CELL; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL;

AUTOIMMUNE DISEASES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HOMEOSTASIS; HUMANS; IMMUNE TOLERANCE; INFECTION; NEOPLASMS; TRANSPLANTATION IMMUNOLOGY;

EID: 57149140898     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.08.280     Document Type: Article

References (79)

1. Mills K.H. Regulatory T cells: Friend or foe in immunity to infection?. Nat Rev Immunol 4 (2004) 841
2. Roncarolo M.G., and Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 7 (2007) 585
3. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4 (2003) 330
4. Shevach E.M. From vanilla to 28 flavors: Multiple varieties of T regulatory cells. Immunity 25 (2006) 195
5. Harrison L.C., Dempsey-Collier M., Kramer D.R., and Takahashi K. Erosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes. J Exp Med 184 (1996) 2167
6. Chen Y., Kuchroo V.K., Inobe J., Hafler D.A., and Weiner H.L. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 265 (1994) 1237
7. Groux H., O'Garra A., Bigler M., Rouleau M., Antonenko S., de Vries J.E., and Roncarolo M.G. A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389 (1997) 737
8. Gorelik L., Constant S., and Flavell R.A. Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. J Exp Med 195 (2002) 1499
9. Liu Z., Tugulea S., Cortesini R., and Suciu-Foca N. Specific suppression of T helper alloreactivity by alloMHC class I-restricted CD8+CD28- T cells. Int Immunol 10 (1998) 775
10. Chang C.C., Ciubotariu R., Manavalan J.S., Yuan J., Colovai A.I., Piazza F., et al. Tolerization of dendritic cells by T(S) cells: The crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 3 (2002) 237
11. Manavalan J.S., Kim-Schulze S., Scotto L., Naiyer A.J., Vlad G., Colombo P.C., et al. Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol 16 (2004) 1055
12. Colovai A.I., Mirza M., Vlad G., Wang S., Ho E., Cortesini R., and Suciu-Foca N. Regulatory CD8+CD28- T cells in heart transplant recipients. Hum Immunol 64 (2003) 31
13. Ciubotariu R., Vasilescu R., Ho E., Cinti P., Cancedda C., Poli L., et al. Detection of T suppressor cells in patients with organ allografts. Hum Immunol 62 (2001) 15
14. Cortesini R., Renna-Molajoni E., Cinti P., Pretagostini R., Ho E., Rossi P., and Suciu-Foca Cortesini N. Tailoring of immunosuppression in renal and liver allograft recipients displaying donor specific T-suppressor cells. Hum Immunol 63 (2002) 1010
15. Jonuleit H., Schmitt E., Schuler G., Knop J., and Enk A.H. Induction of interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192 (2000) 1213
16. Dhodapkar M.V., Steinman R.M., Krasovsky J., Munz C., and Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 193 (2001) 233
17. Yamazaki S., Iyoda T., Tarbell K., Olson K., Velinzon K., Inaba K., and Steinman R.M. Direct Expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med 198 (2003) 235
18. Zhang C., Zhang J., and Tian Z. The regulatory effect of natural killer cells: Do "NK-reg cells" exist?. Cell Mol Immunol 3 (2006) 241
19. Della Chiesa M.V., Carlomagno S., Ferlazzo G., Moretta L., and Moretta A. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur J Immunol 33 (2003) 1657
20. Carosella E.D., Favier B., Rouas-Freiss N., Moreau P., and LeMaoult J. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 111 (2008) 4862
21. Carosella E.D., Moreau P., LeMaoult J., and Rouas-Freiss N. HLA-G: From biology to clinical benefits. Trends Immunol 29 (2008) 125
22. Kovats S., Main E.K., Librach C., Stubblebine M., Fisher S.J., and DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 248 (1990) 220
23. Mallet V., Blaschitz A., Crisa L., Schmitt C., Fournel S., King A., et al. HLA-G in the human thymus: A subpopulation of medullary epithelial but not CD83(+) dendritic cells expresses HLA-G as a membrane-bound and soluble protein. Int Immunol 11 (1999) 889
24. Le Discorde M., Moreau P., Sabatier P., Legeais J.M., and Carosella E.D. Expression of HLA-G in human cornea, an immune-privileged tissue. Hum Immunol 64 (2003) 1039
25. Cirulli V., Zalatan J., McMaster M., Prinsen R., Salomon D.R., Ricordi C., et al. The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. Diabetes 55 (2006) 1214
26. Menier C., Rabreau M., Challier J.C., Le Discorde M., Carosella E.D., and Rouas-Freiss N. Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis. Blood 104 (2004) 3153
27. Selmani Z., Naji A., Zidi I., Favier B., Gaiffe E., Obert L., et al. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells 26 (2008) 212
28. Paul P., Rouas-Freiss N., Khalil-Daher I., Moreau P., Riteau B., Le Gal F.A., et al. HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA 95 (1998) 4510
29. Rouas-Freiss N., Moreau P., Ferrone S., and Carosella E.D. HLA-G proteins in cancer: Do they provide tumor cells with an escape mechanism?. Cancer Res 65 (2005) 10139
30. Lila N., Carpentier A., Amrein C., Khalil-Daher I., Dausset J., and Carosella E.D. Implication of HLA-G molecule in heart-graft acceptance. Lancet 355 (2000) 2138
31. Wiendl H., Mitsdoerffer M., Hofmeister V., Wischhusen J., Weiss E.H., Dichgans J., et al. The nonclassical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: Implications for myoblast transplantation and gene therapy. Brain 126 (2003) 176
32. Khosrotehrani K., Le Danff C., Reynaud-Mendel B., Dubertret L., Carosella E.D., and Aractingi S. HLA-G expression in atopic dermatitis. J Invest Dermatol 117 (2001) 750
33. Aractingi S., Briand N., Le Danff C., Viguier M., Bachelez H., Michel L., et al. HLA-G and NK receptor are expressed in psoriatic skin: A possible pathway for regulating infiltrating T cells?. Am J Pathol 159 (2001) 71
34. Lafon M., Prehaud C., Megret F., Lafage M., Mouillot G., Roa M., et al. Modulation of HLA-G expression in human neural cells after neurotropic viral infections. J Virol 79 (2005) 15226
35. Colonna M., Navarro F., Bellon T., Llano M., Garcia P., Samaridis J., et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 186 (1997) 1809
36. Colonna M., Samaridis J., Cella M., Angman L., Allen R.L., O'Callaghan C.A., et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 160 (1998) 3096
37. Rajagopalan S., and Long E.O. A Human Histocompatibility Leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 189 (1999) 1093
38. van der Meer A., Lukassen H.G.M., van Lierop M.J.C., Wijnands F., Mosselman S., Braat D.D.M., and Joosten I. Membrane-bound HLA-G activates proliferation and interferon-{gamma} production by uterine natural killer cells. Mol Hum Reprod 10 (2004) 189
39. Rajagopalan S., Bryceson Y.T., Kuppusamy S.P., Geraghty D.E., Meer A., Joosten I., and Long E.O. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol 4 (2006) 0070
40. Rouas-Freiss N., Goncalves R.M., Menier C., Dausset J., and Carosella E.D. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 94 (1997) 11520
41. Rouas-Freiss N., Marchal R.E., Kirszenbaum M., Dausset J., and Carosella E.D. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: Is HLA-G the public ligand for natural killer cell inhibitory receptors?. Proc Natl Acad Sci USA 94 (1997) 5249
42. Riteau B., Rouas-Freiss N., Menier C., Paul P., Dausset J., and Carosella E.D. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol 166 (2001) 5018
43. Riteau B., Menier C., Khalil-Daher I., Sedlik C., Dausset J., Rouas-Freiss N., and Carosella E.D. HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol 43 (1999) 203
44. Bahri R., Hirsch F., Josse A., Rouas-Freiss N., Bidere N., Vasquez A., et al. Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes. J Immunol 176 (2006) 1331
45. LeMaoult J., Caumartin J., Daouya M., Favier B., Le Rond S., Gonzalez A., and Carosella E. Immune regulation by pretenders: Cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood 109 (2007) 2040
46. Caumartin J., Favier B., Daouya M., Guillard C., Moreau P., Carosella E., and LeMaoult J. Trogocytosis-based generation of suppressive NK cells. EMBO J 26 (2007) 1423
47. Horuzsko A., Lenfant F., Munn D.H., and Mellor A.L. Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice. Int Immunol 13 (2001) 385
48. Hviid T.V.F. HLA-G in human reproduction: Aspects of genetics, function and pregnancy complications. Hum Reprod Update 12 (2006) 209
49. Fuzzi B., Rizzo R., Criscuoli L., Noci I., Melchiorri L., Scarselli B., et al. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 32 (2002) 311
50. Rouas-Freiss N., Moreau P., Menier C., LeMaoult J., and Carosella E.D. Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses. Semin Cancer Biol 17 (2007) 413
51. LeMaoult J., Krawice-Radanne I., Dausset J., and Carosella E.D. HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci USA 101 (2004) 7064
52. Le Rond S., Azema C., Krawice-Radanne I., Durrbach A., Guettier C., Carosella E.D., and Rouas-Freiss N. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/regulatory T cells. J Immunol 176 (2006) 3266
53. Naji A., Le Rond S., Durrbach A., Krawice-Radanne I., Creput C., Daouya M., et al. CD3+CD4low and CD3+CD8low are induced by HLA-G. Novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance. Blood 110 (2007) 3936
54. Le Rond S., Le Maoult J., Creput C., Menier C., Deschamps M., Le Friec G., et al. Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: In vivo implications in transplanted patients. Eur J Immunol 34 (2004) 649
55. Feger U., Tolosa E., Huang Y.-H., Waschbisch A., Biedermann T., Melms A., and Wiendl H. HLA-G expression defines a novel regulatory T cell subset present in human peripheral blood and sites of inflammation. Blood 110 (2007) 568
56. Wiendl H., Feger U., Mittelbronn M., Jack C., Schreiner B., Stadelmann C., et al. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: Implications for CNS immunity. Brain 128 (2005) 2689
57. Liang S., and Horuzsko A. Mobilizing dendritic cells for tolerance by engagement of immune inhibitory receptors for HLA-G. Hum Immunol 64 (2003) 1025
58. Ristich V., Liang S., Zhang W., Wu J., and Horuzsko A. Tolerization of dendritic cells by HLA-G. Eur J Immunol 35 (2005) 1133
59. Liang S., Ristich V., Arase H., Dausset J., Carosella E.D., and Horuzsko A. Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6-STAT3 signaling pathway. Proc Natl Acad Sci (2008) 0803341105
60. Liang S., Baibakov B., and Horuzsko A. HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. Eur J Immunol 32 (2002) 2418
61. Lila N., Rouas-Freiss N., Dausset J., Carpentier A., and Carosella E.D. Soluble HLA-G protein secreted by allospecific CD4+ T cells suppresses the alloproliferative response: A CD4+ T cell regulatory mechanism. Proc Natl Acad Sci USA 98 (2001) 12150
62. Creput C., Durrbach A., Menier C., Guettier C., Samuel D., Dausset J., et al. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. J Hepatol 39 (2003) 587
63. Pangault C., Le Friec G., Caulet-Maugendre S., Lena H., Amiot L., Guilloux V., et al. Lung macrophages and dendritic cells express HLA-G molecules in pulmonary diseases. Hum Immunol 63 (2002) 83
64. Lozano J.M., Gonzalez R., Kindelan J.M., Rouas-Freiss N., Caballos R., Dausset J., et al. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 16 (2002) 347
65. Nuckel H., Rebmann V., Durig J., Duhrsen U., and Grosse-Wilde H. HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia. Blood 105 (2005) 1694
66. Selmani Z., Naji A., Zidi I., Favier B., Gaiffe E., Obert L., et al. HLA-G5 secretion by human mesenchymal stem cells is required to suppress T-lymphocyte and NK function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells 26 (2008) 212
67. Wiendl H., Mitsdoerffer M., Hofmeister V., Wischhusen J., Bornemann A., Meyermann R., et al. A functional role of HLA-G expression in human gliomas: An alternative strategy of immune escape. J Immunol 168 (2002) 4772
68. Giuliani M., Giron-Michel J., Negrini S., Vacca P., Durali D., Caignard A., et al. Generation of a novel regulatory NK cell subset from peripheral blood CD34+ progenitors promoted by membrane-bound IL-15. PLoS ONE 3 (2008) e2241
69. Joly E., and Hudrisier D. What is trogocytosis and what is its purpose?. Nat Immunol 4 (2003) 815
70. Davis D.M. Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response. Nat Rev Immunol 7 (2007) 238
71. Lee N., Goodlett D.R., Ishitani A., Marquardt H., and Geraghty D.E. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J Immunol 160 (1998) 4951
72. LeMaoult J., Zafaranloo K., Le Danff C., and Carosella E.D. HLA-G upregulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J 19 (2005) 662
73. Contini P., Ghio M., Poggi A., Filaci G., Indiveri F., Ferrone S., and Puppo F. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 33 (2003) 125
74. Fournel S., Aguerre-Girr M., Huc X., Lenfant F., Alam A., Toubert A., et al. Cutting edge: Soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 164 (2000) 6100
75. Rajagopalan S., Fu J., and Long E.O. Cutting edge: Induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J Immunol 167 (2001) 1877
76. Dorling A., Monk N.J., and Lechler R.I. HLA-G inhibits the transendothelial migration of human NK cells. Eur J Immunol 30 (2000) 586
77. Le Gal F.A., Riteau B., Sedlik C., Khalil-Daher I., Menier C., Dausset J., et al. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol 11 (1999) 1351
78. Kanai T., Fujii T., Kozuma S., Yamashita T., Miki A., Kikuchi A., and Taketani Y. Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture. Mol Hum Reprod 7 (2001) 195
79. Fons P., Chabot S., Cartwright J.E., Lenfant F., L'Faqihi F., Giustiniani J., et al. Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood 108 (2006) 2608